Evidence map›Paper›PMID 16314834›Full record

ArticleOncogene2006

GRB2-mediated recruitment of GAB2, but not GAB1, to SF-STK supports the expansion of Friend virus-infected erythroid progenitor cells.

H E Teal, S Ni, J Xu, L D Finkelstein, A M Cheng, R F Paulson, G-S Feng, P H Correll

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Oncogene, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms.Clinical cancer research : an official journal of the American Association for Cancer Research · 2023
    Article
  2. Article
  3. Gab2 mediates hepatocellular carcinogenesis by integrating multiple signaling pathways.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2017
    Article
  4. Review
  5. Article
  6. GAB2--a scaffolding protein in cancer.Molecular cancer research : MCR · 2012
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

H E TealDepartment of Veterinary and Biomedical Science, Center for Molecular Immunology and Infectious Disease, The Pennsylvania State University, University Park, PA 16802-3500, USA.
S Ni
J Xu
L D Finkelstein
A M Cheng
R F Paulson
G-S Feng
P H Correll
Pennsylvania State University · USNational Human Genome Research Institute · USSanford Burnham Prebys Medical Discovery Institute · USWashington University in St. Louis · US

Funding

Role of the STK Receptor in ErythropoiesisR01HL066471 · NHLBI · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI GIBLIN, PAMELA A · 2001 to 2009
$2.3M
GAB2 AND A NOVEL CYTOPLASMIC NUCLEAR SIGNALING MECHANISMR01HL066208 · NHLBI · BURNHAM INSTITUTE FOR MEDICAL RESEARCH · PI FENG, GEN-SHENG · 2001 to 2005
$2.1M
NHLBI NIH HHS R01 HL066471NHLBI NIH HHS R01-HL66208PHS HHS R01-L66471
6 · The paper itself

Abstract

Friend virus induces the development of erythroleukemia in mice through the interaction of a viral glycoprotein, gp55, with a truncated form of the Stk receptor tyrosine kinase, short form-Stk (Sf-Stk), and the EpoR. We have shown previously that the ability of Sf-Stk to participate in the transformation of Friend virus-infected cells requires the kinase activity and Grb2-binding site of Sf-Stk. Here we show that Grb2 heterozygous mice exhibit decreased susceptibility to Friend erythroleukemia and that expansion of erythroid progenitors in response to infection requires the C-terminal SH3 domain of Grb2. A fusion protein in which the Grb2-binding site in Sf-Stk is replaced by Gab2, supports the growth of progenitors from mice lacking Sf-Stk, whereas a Sf-Stk/Gab1 fusion protein does not. Gab2 is expressed in spleens from Friend virus-infected mice, co-immunoprecipitates with Sf-Stk and is tyrosine phosphorylated in the presence of Sf-Stk. Mice with a targeted deletion in Gab2 are less susceptible to Friend erythroleukemia and the expansion of erythroid progenitor cells in response to infection can be rescued by expression of Gab2, but not Gab1. Taken together, these data indicate that a Sf-Stk/Grb2/Gab2 complex mediates the growth of primary erythroid progenitor cells in response to Friend virus.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsErythroid Precursor CellsFemaleFriend murine leukemia virusGRB2 Adaptor ProteinImmunoprecipitationMaleMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutPhosphoproteinsReceptor Protein-Tyrosine KinasesSignal Transductionsrc Homology DomainsAdaptor Proteins, Signal TransducingGab1 protein, mouseGab2 protein, mouseGRB2 Adaptor ProteinGrb2 protein, mousePhosphoproteinsReceptor Protein-Tyrosine KinasesRON protein

Identifiers

PMID16314834
OpenAlexW2019142727

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.